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Whipple’s disease is a systemic disorder associated with a cultivation-resistant, poorly characterized acti-
nomycete, Tropheryma whippelii. We determined a nearly complete rRNA operon sequence of T. whippelii from
specimens from 3 patients with Whipple’s disease, as well as partial operon sequences from 43 patients.
Variability was observed in the 16S-23S rRNA spacer sequences, leading to the description of five distinct
sequence types. One specimen contained two spacer sequence types, raising the possibility of a double infec-
tion. Secondary structure models for the primary rRNA transcript and mature rRNAs revealed rare or unique
features.
Whipple’s disease was described in 1907 (as intestinal lipo-
dystrophy) and is a multisystem disorder of humans involving
the intestinal tract as well as various other organs (3). A con-
stant feature of the disease is the presence in affected tissues of
uniform bacteria that are approximately 0.2 by 1.5 to 2.5 mm.
These bacteria have a characteristic morphology when viewed
with electron microscopy (25). However, numerous attempts to
cultivate this bacterium have failed (3). In 1997, propagation in
human macrophage cell cultures was reported (24), and re-
cently, propagation in human fibroblasts (20), but these find-
ings have not yet been confirmed by other groups. Thus, this
organism remains poorly characterized.
Molecular data from the Whipple’s disease bacterium be-
came available through broad-range 16S ribosomal DNA
(rDNA) PCR and sequence analysis (21, 31). A phylogenetic
assessment based on 1,321 bp of 16S rDNA established the
bacterium (Tropheryma whippelii) as an actinomycete (21).
Taxon-specific 16S rDNA primers have since been used to
detected the bacterium in additional patients with Whipple’s
disease (19, 21, 28, 29), as well as in sewage effluent (16). The
determination of a nearly complete 16S rDNA sequence and
the 16S-23S ribosomal RNA intergenic spacer sequence has
provided additional information (16). A reassessment of its
phylogeny revealed a position between the actinomycetes with
group B peptidoglycan and the family Cellulomonadaceae.
The 16S-23S rDNA spacer has been used for strain differ-
entiation in a variety of bacterial species (4). Two recent stud-
ies, both from the same group in Switzerland, addressed the
potential variability of the 16S-23S ribosomal intergenic spacer
of T. whippelii (5, 6). In the first study, the spacer region was
found to be homogenous in specimens from 9 Swiss individu-
als; in the second study, three types of intergenic spacers were
detected in specimens from 28 individuals. In contrast to the
16S-23S rDNA spacer, little information has been published on
the intraspecies variability of the 23S-5S rDNA spacer and of
regions immediately upstream and downstream of the rRNA
operon.
Because of the paucity of information concerning T. whip-
pelii and the usefulness of the rRNA operon as a source of data
for microbial characterization, we determined and analyzed a
nearly complete rRNA operon sequence directly from tissues
from several patients with Whipple’s disease. In addition, we
analyzed partial operon sequences from 43 patients.
Patients and clinical specimens. A total of 56 clinical spec-
imens from 43 patients with Whipple’s disease who originated
from the United States (11 patients), Germany (28 patients),
Switzerland (3 patients), and Austria (1 patient) were exam-
ined. The specimens comprised 37 intestinal biopsy specimens,
10 cerebrospinal fluid (CSF) samples, 2 brain tissue specimens,
2 lymph node tissue specimens, 1 tissue specimen associated
with prosthetic hip material, 1 colon tissue specimen, 1 ocular
lens capsule specimen, 1 blood sample, and 1 synovial fluid
specimen. All patients, except three patients from the United
States, had Whipple’s disease confirmed by histology. These
three patients had positive PCR results by CSF analysis, and
information on histology was not available. The specimens
were prepared for PCR as previously described (20, 29, 30).
Previously uncharacterized regions of the rRNA operon
were amplified by PCR with primers designed from known T.
whippelii sequences in combination with primers designed
from highly conserved regions of other bacteria (Table 1). To
obtain sequence material downstream of the 5S rRNA gene,
the restriction site PCR method of Sarkar et al. (23) was used
(Table 1). PCRs were performed according to standard proto-
cols using AmpliTaq Gold polymerase (PE Applied Biosys-
tems, Foster City, Calif.). Sequences were determined either
directly from PCR products or after cloning, as described pre-
viously (15).
Primary rRNA operon sequence and phylogeny. A nearly
complete rRNA operon sequence, spanning 5,747 bp, was as-
sembled from PCR products from the intestinal biopsy speci-
men of a patient with Whipple’s disease (patient 1 [17]). Se-
quences from at least three independent clones of each PCR
product (Table 1) were determined. The sequence begins in
the box C element, which is 50 to 380 bp downstream of the
start of transcription in other actinomycetes (7, 9, 10, 18), and
extends from 162 bp upstream of the 16S rRNA gene to 493 bp
downstream of the 5S rRNA gene. The arrangement of rRNA
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genes is in the order 59-16S-23S-5S-39. tRNA genes were not
identified.
Phylogenetic analyses were performed as described previ-
ously (14) for 16S, 23S, and 5S rRNA, utilizing 1,365, 3,033,
and 120 masked nucleotide positions, respectively. Results of
16S rRNA phylogeny were consistent with those of a previous
analysis (15). Both 23S rRNA- and 5S rRNA-based phylog-
enies consistently placed T. whippelii within the Actinobacteria,
while a more detailed resolution of relationships between this
organism and the actinomycetes with group B peptidoglycan
and the cellulomonads was not possible, due to a lack of a
sufficient number of related sequences in both 23S rRNA (2)
and 5S rRNA (27) databases.
Variability of rRNA operon sequences. Two additional
nearly complete operon sequences of 5,722 bp each, ending
with primer tw5745r (Table 1), were determined from a post-
mortem brain tissue specimen (patient 2) and from a CSF
sample (patient 3). The sequence in the sample from patient 2
differed from that of patient 1 at 1 position within the 16S
rRNA leader region, 1 position within the 16S rRNA gene, and
10 positions clustered within a region downstream of the 5S
rRNA gene (between nucleotides 5322 and 5513). The se-
quence in the sample from patient 3 had one difference from
that of patient 1 within the 16S rRNA gene, two in the 16S-23S
ribosomal RNA intergenic spacer, and two in the 23S rRNA
gene.
Several operon regions were sequenced from additional pa-
tient specimens. These included the 16S rRNA gene leader
region (2 specimens from 2 patients; the region between prim-
ers 16Spro1 and tw318r) (Table 1), the 16S-23S ribosomal
intergenic spacer (53 specimens from 40 patients; primers
tw1581f and tw2015r), the region of the insertion in the 23S
rRNA gene (1 specimen from 1 patient; primers tw3002f and
ms38a), and the 23S-5S ribosomal intergenic spacer (2 speci-
mens from 2 patients; primers tw3887f and co5189r). No dif-
ferences between these additional sequences and that deter-
mined from patient 1 were found in the 16S rRNA gene leader
region, the 23S rRNA gene region containing the insertion
(positions 3022 to 4102), and the 23S-5S intergenic spacer
region.
In previous work, three 16S-23S rDNA spacer sequence
types were identified (6, 15). In our study, five types of 16S-23S
ribosomal RNA intergenic spacer sequences were found. Type
1 was defined as the original sequence determined for this
spacer region (15); it corresponded to the sequence of patients
1 and 2 as described above and was found in a total of 16
specimens from 14 patients. Type 2 (6) was most frequently
detected; it corresponded to that of patient 3 and was found in
36 specimens from 26 patients. Type 3, as defined by Hinrikson
et al. (6), was not found in any specimen. Types 4 through 6
have not been previously described and were each found in
single patients (designated patients 4 to 6). There were a total
of 10 variable nucleotide positions and two to six differences
with the type 1 sequence. The differences, with reference to
type 1 and numbered according to this type’s 294-bp spacer
sequence, were as follows: type 2, T56C and D86; type 4, A94G,
C98T, G115A, and G200A; type 5, A94G, G115A, and G200A;
type 6, T56C, D86, C124T, C143T, T148C, and A157G. To
confirm the existence of distinct spacer types by an indepen-
dent method, PCR products (primers tw1581f and tw2015r)
from each of these types were subjected to digestion with the
restriction endonucleases HaeII, HinfI, MseI, MslI, XmnI, and
TaaI. Distinct and expected band patterns were obtained for
each spacer type.
There were 11 patients from whom more than one specimen
was examined. These comprised five patients from Germany
and one from Switzerland with more than one intestinal biopsy
specimen, four patients from Germany with intestinal biopsy
and CSF specimens, and one patient from the United States
(patient 6) with an intestinal biopsy and a blood specimen.
TABLE 1. PCR primers and amplified regions within the rRNA operon sequence of T. whippelii
Primer pair Region amplifieda Source and/or reference(s)for primers
16Spro1 (59-TTGAGAACTCAABAGYGTG-39) and tw318r
(59-CGAAGTTATCCCAAAGTTAG-39)
1–298 This work
fD1mod (59-AGAGTTTGATCYTGGYTYAG-39) and whip2
(59-ATTCGCTCCACCTTGCGA-39)
193–1404 21, 28, 30
whip1 (59-AGAGATACGCCCCCCGCAA-39) and 23S rDNA primer 2
(59-GGTACCTTAGATGTTTCAGTTC-39)
1176–2182 12, 21, 28
tw1581f (59-GTGACTTAACCTTTTTGGAGA-39) and tw2015r
(59-GCATCCACCATTTGCTCTTAAA-39)
1602–1993 This work
tw1974f (59-GTATTTGTGATTCAAGCTAC-39) and ms37ar
(59-CTGCTTCTAAGCCAACATCCT-39)
1994–3136 This work; 13
tw3002f (59-TGCCGGTAAGTTAGAGCGCA-39) and ms38a
(59-GACAAGGAATTTCGCTACCTTA-39)
3022–4102 This work; 13
tw3887f (59-GCCTGAGGCGTGACGAG-39) and co5189r
(59-GCTTCCGGGTTCGGAATG-39)
3904–5171 This work
tw5104f (59-CTTGATGTGCGGCCCTTTGC-39) and tw5745r
(59-AAGATCCCACTGCACTGACATCG-39)
5124–5722 This work
tw5068f (59-ATTGCTTGAAACACATTTTG-39) or tw5104f and NheI-RSO
(59-AATACGACTCACTATAGGN10GCTAGC-39)
5124–5747 This work; 23
a In sequence AF190686. Primers are excluded.
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Multiple clones from individual PCR products (range, 2 to 10
clones) were sequenced for 19 patients. In all instances (except
for patient 5, whose case is discussed below), 16S-23S spacer
types were consistent among different clinical samples from the
same patient and between different clones of the same PCR
product. This is consistent with the hypothesis that a single
bacterial clone undergoes systemic dissemination (29) and is
further supported by the results from patient 3, who had an
intestinal biopsy taken in 1987 and two CSF specimens taken in
1998 and 1999, all with identical spacer types, and by the
results of patient 6, whose samples from different sites yielded
the same, unique type 6 spacer sequence. Nucleotide differ-
ences observed elsewhere in the operon sequence did not cor-
relate with 16S-23S spacer type.
Geographic analysis of 16S-23S spacer types showed that 10
of 28 German patients had type 1, 17 had type 2, and 1 had a
mixed type 2 and 5 infection (discussed below). Of 11 patients
from the United States, 3 had type 1, 7 had type 2, and 1 had
type 6. Of three patients from Switzerland, two had type 2, and
one had type 1. The single patient from Austria had a type 4
sequence. While the number of specimens from each area is
relatively small, it appears clear that the two common types
(types 1 and 2) are observed at similar frequencies in patients
from both the United States and Europe, suggesting that a
differential distribution of T. whippelii between the Old World
and the New World, such as has been described for Borrelia
burgdorferi sensu lato and its genospecies (1), is unlikely.
The five 16S-23S rRNA spacer types found in our 43 patients
expand our understanding of T. whippelii sequence diversity
(6). Whipple’s disease was confirmed by histological methods
in all but 3 of our 43 patients. We found a predominance of
spacer type 2 (65%), whereas the Swiss study (6) described a
predominance of type 1. The previously reported uniformity of
spacer type 1 in Swiss individuals (5) could not be confirmed.
Sequence variability within a single host. In the case of
patient 5, four clones of the PCR-amplified 16S-23S spacer
were sequenced: three yielded an identical but novel type 5
sequence, and one contained a type 2 sequence. Direct se-
quencing and restriction endonuclease analysis of the PCR
product revealed expected sequence ambiguities correspond-
FIG. 1. Proposed secondary structure model of the primary RNA transcript of the T. whippelii rRNA operon. Helices are numbered according to their location in
the leader (L), the 59 portion of the 16S-23S rRNA spacer (S1a), the 39 portion of the 16S-23S rRNA spacer (S1b), and the 23S-5S rRNA spacer (S2). Helix T is a
putative Rho-independent terminator. The locations of the primer 16Spro1 and the regulatory elements (box A and box C) are indicated by braces. Numbers and
nucleotides in boxes indicate 16S-23S rRNA spacer types and nucleotide changes in these types, respectively. Helix S1b-1 contains a putative box B element. Asterisk,
no information is available for this nucleotide in 16S-23S rRNA spacer types 4 and 5.
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ing to differences between sequence types 2 and 5. These
findings suggest that both sequence types were present in the
patient’s specimen and raise two possibilities: either the bac-
terium has more than one rRNA operon, or the patient was
infected by two different bacterial strains. While it is not pos-
sible to draw a firm conclusion between these two alternatives,
there are two findings consistent with the notion of a single
rRNA operon in T. whippelii. First, there was concordance of
rRNA spacer type between different clinical samples and
clones of PCR products from specimens from each of the other
patients (discussed above). Second, amplification of genomic
DNA flanking the 39 end of the operon by restriction site PCR
(24) from the specimen of patient 1 generated two fragments
in the same reaction, yielding 491- and 677-bp sequences, re-
spectively; the sequence of the 491-bp fragment extended 206
bp downstream of the 5S rRNA gene and was identical to the
sequence of the 677-bp PCR product in the region of overlap.
Thus, this initial analysis failed to find variability in the genome
adjacent to, but outside of, the rRNA operon. For comparison,
in the Mycobacterium tuberculosis genome (accession no.
Z73902), a non-rRNA gene begins 120 bp downstream of the
5S rDNA. Thus, the second explanation, i.e., a dual infection
by different T. whippelii strains, appears more likely.
Structural and regulatory features of the primary RNA
transcript. A secondary structure model of the primary rRNA
transcript was constructed by visual comparison to published
structures (7–11, 18), with some assistance from the Mfold
program (Genetics Computer Group, Madison, Wisc.). The
proposed model is shown in Fig. 1. This model is consistent
with published models for other members of the class Acti-
nobacteria (7–11, 19) and shows two stems, one bracketing
pre-16S rRNA and consisting of the 16S rRNA leader region
and the 59 portion of the 16S-23S rRNA spacer (spacer 1a),
and another bracketing pre-23S rRNA and consisting of the 39
portion of the 16S-23S rRNA spacer (spacer 1b) and the
23S-5S rRNA spacer (spacer 2). The 59 end of the model
begins with primer 16Spro1, which is located within and be-
tween the box A and box C elements of the operon leader
region. The polymorphic positions within the 16S-23S spacer
were mapped on the secondary structure model (Fig. 1). Ac-
cording to the model, all nucleotide differences between 16S-
23S spacer types either are located in loops, where they are not
involved in base pairing, or create tolerated changes in paired
positions that preserve the structure.
Structural features associated with mature rRNAs. Putative
secondary structures of 16S, 23S, and 5S rRNAs were inferred
by manual alignment to published structures (18; http://ww-
w.rna.icmb.utexas.edu/). The proposed model for 5S rRNA
(data not shown) was identical to a previously-published model
for Streptomyces ambofaciens (18), except for a paired set of
nucleotides in T. whippelii 5S rRNA (G20 and C63). Several
regions in the T. whippelii predicted 16S and 23S rRNA sec-
ondary structures were found to differ from those of other
actinomycetes (http://www.rna.icmb.utexas.edu/) (Fig. 2). Most
of these variable regions involved differences in helix length
and unpaired or unilateral bulges along helix stems. Three
features of the 16S rRNA and 23S rRNA, however, were found
to be unique to T. whippelii, after comparison with a larger set
of structures and sequences (10,073 16S rRNA and 503 23S
rRNA bacterial sequences). One of these features is the ab-
sence of an otherwise conserved pairing between 16S rRNA
positions 945 and 954 in helix 33 (Fig. 2). The second was
observed in the vicinity of the stem formed by the 59 and 39
ends of mature 23S rRNA (Fig. 2). Here, the central loop of
23S rRNA consists of eight nucleotides, whereas six are
present in nearly all other bacterial 23S rRNAs. The third
feature was located in helix I3 of 23S rRNA; it consisted of two
noncanonical G-A pairings at the end of the helix, closed by a
pentaloop. Except for Micrococcus luteus, which has the same
constellation, all other bacteria in the database have a shorter
helix without G-A pairings, closed by a tetraloop. G-A pairings
are only observed in archaea and eukaryotes.
The insertion sequences of high-G1C-content gram-positive
bacteria in the 23S rRNA determined by Roller et al. (22) were
visually examined for possible conserved base pairings and
covariation at paired positions, and the T. whippelii insertion
sequence was aligned to these sequences with the ARB pro-
gram package (26). The insertion of T. whippelii (80 bp) was
quite different from the insertions of other actinomycetes (86
to 116 bp) with respect to both length and primary sequence. It
had similarity values of only 25 to 43% with those of other
actinomycetes, while the other previously determined insertion
sequences (22) had values of 42 to 81% among each other.
This significant divergence from the other actinomycetes
seems intriguing and suggests an unusual evolutionary history
for this organism.
Conclusions. The nearly complete T. whippelii rRNA operon
sequence is currently the largest body of molecular data for
this medically important organism, an organism that has oth-
erwise resisted characterization. The sequence will provide
targets for new diagnostic primers and probes. Several features
are particularly noteworthy, such as (i) the very low degree of
nucleotide similarity of the 23S rRNA insertion with those of
other actinomycetes and (ii) rare or unique rRNA secondary
structures, which support a relatively distant relationship of T.
whippelii to the cultivated members of the Actinobacteria. The
possibility of dual infection of a host by two T. whippelii strains
is raised for the first time. Our identification of new 16S-23S
rRNA intergenic spacer types and downstream genomic poly-
morphisms may facilitate further analysis of the ecology of this
organism and the epidemiology of Whipple’s disease.
Nucleotide sequence accession numbers. The rRNA operon
sequence determined from patient 1 has been deposited in the
GenBank and EMBL databases under the accession no.
AF190686. The operon sequences of patients 2 and 3 and the
16S-23S ribosomal RNA intergenic spacer types 4 to 6 of
patients 4, 5, and 6 have been assigned accession no. AF190687
through AF190691. The secondary structures of 16S rRNA and
23S rRNA have been deposited at the rRNA secondary struc-
ture website (http://www.rna.icmb.utexas.edu/).
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